<?xml version="1.0" encoding="UTF-8"?>
<p id="par0055">Thus, due to the different pathogenic mechanisms intervening in early stage versus late stage of SARS-CoV-2 infection (reviewed in [
 <xref rid="bib0085" ref-type="bibr">17</xref>]) and to the role of comorbidities in disease exacerbation, interventions should be carefully tailored to the stage of the disease and to the target population with the aim of avoiding the progression to severe clinical manifestations.
</p>
